Details for New Drug Application (NDA): 020499
✉ Email this page to a colleague
NDA 020499 describes ACTRON, which is a drug marketed by Bayer and is included in one NDA. Additional details are available on the ACTRON profile page.
The generic ingredient in ACTRON is ketoprofen. There are twenty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.
The generic ingredient in ACTRON is ketoprofen. There are twenty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.
Summary for 020499
| Tradename: | ACTRON |
| Applicant: | Bayer |
| Ingredient: | ketoprofen |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020499
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 12.5MG | ||||
| Approval Date: | Oct 6, 1995 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
